E-LIB Suche - Ergebnisse für: Khan, Qasim Rana

1

Tu1741 EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH MODERA..:

Mukherjee, Richa S. ; Khan, Qasim Rana ; Liu, Julia J....
Gastroenterology. 164 (2023) 6 - p. S-1104-S-1105 , 2023

Link: https://doi.org/10.1016/..

2

Health Care Costs and Resource Utilization Among Patients W..:

Chen, Grace ; Pedarla, Vasantha ; Null, Kyle D...
Inflammatory Bowel Diseases. 28 (2021) 6 - p. 870-877 , 2021

Link: https://doi.org/10.1093/..

3

Low Frequency of Opportunistic Infections in Patients Recei..:

Ng, Siew C ; Hilmi, Ida Normiha ; Blake, Aimee...
Inflammatory Bowel Diseases. 24 (2018) 11 - p. 2431-2441 , 2018

Link: https://doi.org/10.1093/..

4

Incidence of suboptimal response to tumor necrosis factor a..:

Yamamoto-Furusho, Jesus K. ; Al Harbi, Othman ; Armuzzi, Alessandro...
Digestive and Liver Disease. 52 (2020) 8 - p. 869-877 , 2020

Link: https://doi.org/10.1016/..

5

Vedolizumab, Adalimumab, and Methotrexate Combination Thera..:

Colombel, Jean-Frederic ; Ungaro, Ryan C. ; Sands, Bruce E....
Clinical Gastroenterology and Hepatology. 22 (2024) 7 - p. 1487-1496.e12 , 2024

Link: https://doi.org/10.1016/..

6

ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dos..:

Jairath, Vipul ; Yarur, Andres ; Osterman, Mark T....
Clinical Gastroenterology and Hepatology. 22 (2024) 5 - p. 1077-1086.e13 , 2024

Link: https://doi.org/10.1016/..

7

Clinical Trial Design in Ulcerative Colitis: Interpreting E..:

Sandborn, William J ; Sands, Bruce E ; Uddin, Sharif..
Crohn's & Colitis 360. 6 (2023) 1 - p. , 2023

Link: https://doi.org/10.1093/..

8

Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 ..:

van Damme, Pierre ; Kafeja, Froukje ; Anemona, Alessandra...
PLoS ONE. 6 (2011) 9 - p. e25398 , 2011

Link: https://doi.org/10.1371/..

9

Health Care Costs and Resource Utilization Among Patients W..:

Chen, Grace ; Pedarla, Vasantha ; Null, Kyle D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165558/. , 2021

Link: http://www.ncbi.nlm.nih...

10

P432 Barriers to prescribing anti-TNF therapy in inflammato..:

Ye, B D ; Yamamoto Furusho, J K ; Rana Qasim Khan, M...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S324-S325 , 2019

Link: https://doi.org/10.1093/..

11

Low Frequency of Opportunistic Infections in Patients Recei..:

Ng, Siew C ; Hilmi, Ida Normiha ; Blake, Aimee...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185254/. , 2018

Link: http://www.ncbi.nlm.nih...

12

885: TRIPLE COMBINATION THERAPY WITH VEDOLIZUMAB, ADALIMUMA..:

Colombel, Jean Frederic ; Ungaro, Ryan C. ; Sands, Bruce E....
Gastroenterology. 162 (2022) 7 - p. S-215 , 2022

Link: https://doi.org/10.1016/..

13

791: A RANDOMIZED TRIAL OF VEDOLIZUMAB DOSE OPTIMIZATION IN..:

Osterman, Mark T. ; Jairath, Vipul ; Rana-Khan, Qasim...
Gastroenterology. 162 (2022) 7 - p. S-190-S-191 , 2022

Link: https://doi.org/10.1016/..

14

Vedolizumab Clinical and Post-Marketing Safety Experience o..:

Ng, Siew C. ; Palo, William ; Blake, Aimee..
Gastroenterology. 152 (2017) 5 - p. S575-S576 , 2017

Link: https://doi.org/10.1016/..

15

Smart Safety Belt Design to Avoid Accidents in Hazardous In..:

Yaseen, Muhammad ; Khan, Saad Qasim ; Khurram, Muhammad.
International Journal of Reconfigurable and Embedded Systems (IJRES). 5 (2016) 2 - p. 111 , 2016

Link: https://doi.org/10.11591..